Company: RCUS
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001724521-25-000052
Chunk: 38

Company: Arcus Biosciences, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 38
---
 acquired within 60 days is the number of shares that may be acquired pursuant to the terms of the Third Amended and Restated Common Stock Purchase Agreement, dated January 29, 2024 between Gilead and us, which number is the maximum that will cause Gilead’s beneficial ownership to be 35.0% subsequent to the issuance of such shares. The principal business address of Gilead is 333 Lakeside Drive, Foster City, California 94404.

(2) Based on Schedule 13G/A filed with the SEC on November 8, 2024 by BlackRock, Inc. Blackrock, Inc. has sole dispositive power with respect to all of these shares and sole voting power with respect to 9,732,399 of these shares. Blackrock Fund Advisors may also be deemed to beneficially own 5% or more of our outstanding shares of common stock. The principal business address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.

(3) Based on a Schedule 13F-HR filed with the SEC on February 11, 2025, reporting that as of December 31, 2024, The Vanguard Group, Inc. had the sole dispositive power with respect to 5,226,631 of these shares, the shared power to dispose of 60,857 of these shares and the shared power to vote and to dispose of 101,728 of these shares. This number is also adjusted to reflect 772,727 shares of our common stack that such beneficial owner and/or its affiliates purchased in the underwritten equity offering that we closed in February 2025.

(4) Shares owned includes 632,974 shares of common stock held in family trusts in which Dr. Rosen has no pecuniary interest but retains voting and dispositive power.

(5) Shares owned includes 1,188,233 shares of common stock held by trusts.

(6) Dr. Nuyten departed the Company in January 2025.

<div align='center'>20.</div>

(7) Shares owned includes 102,106 shares of common stock held by trusts.

(8) Shares owned consists of (a) 505,050 shares of common stock held by Kaneko Capital, LLC, (b) 252,524 shares of common stock held by Kaneko Investments, LLC, and (c) 152,981 shares of common stock held by trusts.

(9) Shares owned